New HealthWell Fund Established to Support Neuroendocrine Tumor Patients
On April 16, 2025, the HealthWell Foundation® announced the opening of a new fund designed specifically to assist individuals diagnosed with neuroendocrine tumors (NETs). This independent non-profit organization is known for providing financial support to underinsured individuals across various healthcare challenges, and this initiative aims to alleviate some of the financial burdens associated with NET treatment.
Neuroendocrine tumors are a unique class of tumors that can appear in various parts of the body, most commonly within the digestive system, lungs, and pancreas. These tumors, although they can be slow-growing, often present significant challenges in diagnosis and treatment. Symptoms of NETs may mimic those of other diseases, leading to misdiagnoses for extended periods, sometimes up to five years. Common symptoms include abdominal pain, flushing, weight changes, and heart palpitations, among others. As awareness surrounding NETs increases, the annual diagnosis rate has grown by over five percent, impacting an estimated 175,000 patients currently living in the United States.
Through this new fund, HealthWell Foundation aims to provide eligible patients with up to $15,000 to assist with medication copayments or insurance premiums for prescription drugs and biologics essential for the treatment of their condition. To qualify, individuals must have household incomes that do not exceed 500 percent of the federal poverty level. This financial support is pivotal in ensuring that patients do not have to compromise on their treatment due to the high costs associated with necessary medical care.
Maryann Wahmann, the Executive Director of the Neuroendocrine Cancer Awareness Network (NCAN), highlighted the emotional and financial hardships that accompany a NET diagnosis. Having lived with neuroendocrine cancer for over two decades herself, Wahmann expressed her support for the HealthWell Foundation's commitment to challenging the financial constraints that many patients face. The burden of treatment is extensive and can often be a significant barrier to accessing life-saving medication.
Michael S. Heimall, President and CEO of HealthWell Foundation, emphasized the organization's excitement in expanding their portfolio of disease funds to include those with neuroendocrine tumors. He thanked the foundation's donors for their generosity, which enables the organization to fulfill this critical need in the healthcare community. The financial relief offered aims to allow patients to concentrate on complying with their treatment plans rather than the cost of care.
For those interested in determining their eligibility for assistance, more information can be found on HealthWell's dedicated Neuroendocrine Tumors Fund page. The fund will accept applications from 11:00 AM Eastern Daylight Time on weekdays, and further details regarding all programs and resources are available on their official website, HealthWellFoundation.org.
The Neuroendocrine Cancer Awareness Network, an integral partner in this initiative, is dedicated to improving awareness around neuroendocrine cancer, supporter engagement, and funding vital research. Since its founding in 2003, NCAN has advocated for the NET community, striving to enhance understanding and provide necessary support to patients and caregivers alike.
As healthcare continues to evolve, efforts like those of the HealthWell Foundation are essential in creating a safety net for individuals struggling with the financial implications of their medical conditions. By addressing such critical gaps, the foundation not only affirms its commitment to patient support but also reinforces the importance of accessible healthcare for all, regardless of their financial situation.
For further insights into the remarkable work done by HealthWell and NCAN, or to make a donation toward this important cause, you can visit their respective websites.
Neuroendocrine tumors are a unique class of tumors that can appear in various parts of the body, most commonly within the digestive system, lungs, and pancreas. These tumors, although they can be slow-growing, often present significant challenges in diagnosis and treatment. Symptoms of NETs may mimic those of other diseases, leading to misdiagnoses for extended periods, sometimes up to five years. Common symptoms include abdominal pain, flushing, weight changes, and heart palpitations, among others. As awareness surrounding NETs increases, the annual diagnosis rate has grown by over five percent, impacting an estimated 175,000 patients currently living in the United States.
Through this new fund, HealthWell Foundation aims to provide eligible patients with up to $15,000 to assist with medication copayments or insurance premiums for prescription drugs and biologics essential for the treatment of their condition. To qualify, individuals must have household incomes that do not exceed 500 percent of the federal poverty level. This financial support is pivotal in ensuring that patients do not have to compromise on their treatment due to the high costs associated with necessary medical care.
Maryann Wahmann, the Executive Director of the Neuroendocrine Cancer Awareness Network (NCAN), highlighted the emotional and financial hardships that accompany a NET diagnosis. Having lived with neuroendocrine cancer for over two decades herself, Wahmann expressed her support for the HealthWell Foundation's commitment to challenging the financial constraints that many patients face. The burden of treatment is extensive and can often be a significant barrier to accessing life-saving medication.
Michael S. Heimall, President and CEO of HealthWell Foundation, emphasized the organization's excitement in expanding their portfolio of disease funds to include those with neuroendocrine tumors. He thanked the foundation's donors for their generosity, which enables the organization to fulfill this critical need in the healthcare community. The financial relief offered aims to allow patients to concentrate on complying with their treatment plans rather than the cost of care.
For those interested in determining their eligibility for assistance, more information can be found on HealthWell's dedicated Neuroendocrine Tumors Fund page. The fund will accept applications from 11:00 AM Eastern Daylight Time on weekdays, and further details regarding all programs and resources are available on their official website, HealthWellFoundation.org.
The Neuroendocrine Cancer Awareness Network, an integral partner in this initiative, is dedicated to improving awareness around neuroendocrine cancer, supporter engagement, and funding vital research. Since its founding in 2003, NCAN has advocated for the NET community, striving to enhance understanding and provide necessary support to patients and caregivers alike.
As healthcare continues to evolve, efforts like those of the HealthWell Foundation are essential in creating a safety net for individuals struggling with the financial implications of their medical conditions. By addressing such critical gaps, the foundation not only affirms its commitment to patient support but also reinforces the importance of accessible healthcare for all, regardless of their financial situation.
For further insights into the remarkable work done by HealthWell and NCAN, or to make a donation toward this important cause, you can visit their respective websites.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.